BMPR2 and interstitial lung disease: We have reviewed many emerging therapeutic targets based on important molecular mechanisms in PH associated with both ILD and COPD, which include BMPR2, angiogenesis, NF-κB, RAS, PPARγ, EndoMT, adrenergic stimuli, and HIF signaling.